Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A indicate strong financial performance and strategic growth potential. Despite short-term EBITDA losses, the company has increased revenue guidance and strong demand signals. The Starlab project and defense sector growth are positive catalysts. While some management responses lacked detail, the overall sentiment is optimistic, suggesting a positive stock price reaction.
Defense and National Security segment growth 59% year-over-year increase, driven by execution on Next Generation Interceptor and other classified programs.
Backlog Increased 33% year-over-year, entering 2026 with $266 million to support growth.
Funds raised Over $1 billion raised in 2025, including a successful IPO and issuing a follow-on convertible note, strengthening liquidity for innovation and growth.
Innovation spend Increased to over 20% of revenue in 2025, aimed at strengthening competitive moats and addressing growing markets.
Net sales (Q4) Increased 24% year-over-year, driven by strong execution in Defense and National Security segment.
Adjusted EBITDA (Q4) Loss of $21.8 million compared to a loss of $6.3 million last year, reflecting investments in innovation, talent acquisition, and corporate infrastructure.
Adjusted EPS (Q4) Loss of $0.37 compared to a loss of $2.09 in the prior year, reflecting a higher share count post-IPO.
Defense and National Security net sales (Q4) Increased 63% year-over-year, driven by execution on Next Generation Interceptor and classified programs.
Space Solutions net sales (Q4) Declined 29% year-over-year due to the anticipated conclusion of a multiyear NASA services contract.
Net sales (Full Year 2025) Increased 15% year-over-year, or 33% excluding the planned wind down of the legacy NASA contract.
Adjusted EBITDA (Full Year 2025) Loss of $69.9 million compared to a loss of $30 million last year, reflecting investments in innovation and scaling operations.
Adjusted EPS (Full Year 2025) Loss of $2.05 compared to a loss of $5.72 in the prior year.
Defense and National Security net sales (Full Year 2025) Increased 59% year-over-year, driven by growth in Next Generation Interceptor and classified ISR Programs.
Space Solutions net sales (Full Year 2025) Declined 36% year-over-year, primarily due to the planned wind down of a legacy NASA services contract.
Starlab milestones Achieved 31 program milestones to date, generating $183 million of cash receipts from NASA.
Liquidity Ended 2025 with $491 million in cash and access to $213 million in credit facilities, totaling over $700 million in liquidity.
Orbital Data Center: Launched the first space-hardened, managed cloud infrastructure to the International Space Station.
AI-enabled Edge Computing: Introduced new AI-enabled edge computing products.
Extraterrestrial Manufacturing: Patented a manufacturing method for high-performance optical communications.
Dust Repellent Coating: Developed a patented Dust Repellent Coating technology that landed on the moon.
Defense and National Security: Segment grew 59% year-over-year, driven by programs like Next Generation Interceptor.
Starlab Commercial Payload: Fully reserved commercial payload capacity, indicating strong demand.
Voyager American Defense Complex: Broke ground on a 150,000 square feet facility for advanced manufacturing and testing.
Backlog Growth: Backlog increased 33% year-over-year to $266 million.
Acquisitions: Completed and integrated several acquisitions to expand capabilities.
Innovation Spend: Increased innovation spend to over 20% of revenue, focusing on R&D and strategic campaigns.
Vertical Integration: Deepened vertical integration in missile defense systems through acquisitions like Estes Energetics.
Starlab Development: Transitioning to full-scale procurement and development, with 31 milestones achieved to date.
Strategic Partnerships: Formed partnerships with universities and established VISTA to accelerate the commercial space economy.
Government Shutdown: The company faced challenges due to a prolonged government shutdown, which could have impacted operations and financial performance.
Increased R&D and Talent Investments: The company reported losses in adjusted EBITDA due to increased investments in research and development, talent acquisition, and corporate infrastructure, which could strain financial resources in the short term.
Space Solutions Revenue Decline: The Space Solutions segment experienced a 29% year-over-year decline in net sales due to the planned conclusion of a multiyear NASA services contract, impacting overall revenue.
Dependence on Government Contracts: A significant portion of the company's revenue and growth is tied to government contracts, such as NASA and Department of War programs, making it vulnerable to changes in government priorities or funding.
Supply Chain Sovereignty and Manufacturing Capacity: The company highlighted the importance of onshore manufacturing and supply chain sovereignty, indicating potential risks if these are not adequately managed.
High Innovation Spend: The company plans to increase innovation spending to over 20% of revenue, which, while aimed at long-term growth, could pressure margins and financial stability in the near term.
Starlab Investment Risks: The Starlab project requires significant investment and is not yet revenue-generating, posing financial risks if milestones or funding do not materialize as planned.
Profitability Challenges: The company reported losses in adjusted EBITDA and adjusted EPS, reflecting ongoing challenges in achieving profitability.
Revenue Guidance for 2026: The company has raised its 2026 revenue guidance to a range of $225 million to $255 million, representing growth of 35% to 53% year-over-year. This acceleration is driven by demand for Defense and National Security technologies, including programs aligned with Golden Dome and contributions from acquisitions.
Starlab Development: 2026 will be a pivotal year for Starlab as it transitions to full-scale procurement and development. NASA is expected to release the RFP for the second phase of the Commercial LEO Development program, with a decision anticipated later in the year. Starlab's commercial payload capacity is fully reserved, indicating strong demand and revenue potential.
Capital Expenditures and Investments: Capital expenditures, excluding Starlab, are expected to be approximately $60 million to $70 million in 2026. Investments will focus on scaling domestic energetics and munitions production, advanced electronics, propulsion capacity, and product line enhancements. Internally funded R&D will increase to approximately 20% of net sales, advancing mission-critical capabilities aligned with customer priorities.
Gross Margin and Financial Targets: Gross margin for 2026 is expected to be in the mid-teens, reflecting targeted investments in manufacturing capacity ahead of growth acceleration. The company continues to target a long-term organic growth CAGR of 25%, gross margins of 30%-35%, mid-teens adjusted EBITDA margin (excluding Starlab), and low teens free cash flow margin (excluding Starlab).
Expansion of Manufacturing Facilities: The company has broken ground on the Voyager American Defense Complex in Colorado, a 150,000-square-foot facility for advanced manufacturing, operations, and testing. This facility is designed to support high-volume production of military-grade components, propulsion systems, and energetics to meet increasing demand from the Department of War.
Innovation and Technology Development: The company plans to accelerate innovation spending to strengthen competitive advantages and capitalize on growing addressable markets. Focus areas include AI and autonomous industrialization, propulsion and navigation, and mission-critical advanced electronics.
The selected topic was not discussed during the call.
The earnings call summary presents a mixed picture. Financial performance and shareholder return plans are positive, with strong cash reserves and expected revenue growth. However, the Q&A reveals uncertainties, such as increased debt ratios, credit rating downgrades, and lack of clarity on acquisitions and growth targets. These factors balance out the positives, leading to a neutral sentiment. Additionally, the absence of a market cap makes it difficult to gauge the stock's volatility, further supporting a neutral prediction for the stock price movement.
The earnings call summary and Q&A indicate strong financial performance and strategic growth potential. Despite short-term EBITDA losses, the company has increased revenue guidance and strong demand signals. The Starlab project and defense sector growth are positive catalysts. While some management responses lacked detail, the overall sentiment is optimistic, suggesting a positive stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.